Elvira Mora

8PUBLICATIONS
67CO-AUTHORS
Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)Medical mycologyMedical microbiology not elsewhere classifiedTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 04, 2026
Survival outcomes and treatment patterns in myelofibrosis in the JAK inhibitor era.

|Oct 28, 2025
Optical genome mapping in myelofibrosis: enhancing prognostic accuracy through high-resolution genomic profiling.

Álvaro Díaz-González, Elvira Mora, Marta Garrote

|Apr 17, 2025
Real world outcomes of momelotinib in myelofibrosis patients with anemia: results from the MOMGEMFIN study.

Lucía Pérez-Lamas, Adrián Segura Diaz, Regina García Delgado

|Oct 10, 2024
AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular.

Sandra Castaño-Díez, Mònica López-Guerra, Inés Zugasti

|Aug 30, 2024
Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis.

Irene Pastor-Galán, Arturo Pereira, Eduardo Arellano-Rodrigo

|May 16, 2024
Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia.

Elvira Mora, Juan Montoro, Aitana Balaguer

Pageof 2

Frequent Collaborators

4 joint publications

Juan-Carlos Hernández-Boluda

3 joint publications

Francisca Ferrer-Marín

3 joint publications

Manuel Pérez-Encinas

3 joint publications

Eduardo Arellano-Rodrigo